Send to

Choose Destination
Clin Exp Rheumatol. 2001 Mar-Apr;19(2):197-200.

Scleroderma in association with the use of docetaxel (taxotere) for breast cancer.

Author information

Department of Rheumatology, Westmead Hospital, Australia.


The taxanes, paclitaxel (Taxol) and docetaxal (Taxotere), are a new class of anti-microtubule agents which have shown cytotoxic activity in a number of solid tumours. Phase I and II trials confirm that docetaxal is highly active in the treatment of metastatic breast cancer. Reported toxicities of docetaxel include, dose limiting neutropenia, alopecia, skin reactions and fluid retention. Here we report the first case of rapid onset, diffuse scleroderma-like illness, which occurred in a 59-year-old female receiving treatment with docetaxel for locally invasive and advanced metastatic breast cancer.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center